美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

艾格里房產

74.80

-0.3400-0.45%

盤後：74.800.00000.00%19:14 EDT

成交量：106.07萬

成交額：7,973.05萬

市值：85.97億

市盈率：43.69

高：75.89

開：75.14

低：74.69

收：75.14

52周最高：79.65

52周最低：67.58

股本：1.15億

流通股本：1.08億

量比：0.80

換手率：0.98%

股息：3.05

股息率：4.08%

每股收益(TTM):1.71

每股收益(LYR):1.79

淨資產收益率：3.48%

總資產收益率：2.33%

市淨率：1.51

市盈率(LYR):41.72

資料載入中...

總覽公司新聞公告

百利天恆(688506.SH)：T-Bren(HER2 ADC)用於在HER2陽性局部晚期或轉移性胃或胃食管結合部腺癌III期臨牀試驗完成首例受試者入組

中國生物製藥(01177)：TQB2102「HER2雙抗ADC」納入突破性治療藥物程序

港股異動 | 映恩生物-B(09606)盤中漲超5% 公司首款ADC有望於年內提交上市申請

基石藥業-B(02616)將公佈PD-1/VEGF/CTLA-4三抗I期劑量遞增臨牀數據和ROR1 ADC最新研究設計

Macrogenics, Inc.盤中異動下午盤快速下跌5.43%報1.66美元

禮來(LLY.US)FRα ADC啓動III期臨牀研究

ADC走到深度競爭時代：三家企業圍着一條管線轉

十月開門紅可期，黃金板塊還有戲

扬子晚报网

第一三共公佈TROPION-Breast02 Ⅲ期研究積極的主要結果

映恩生物-B大幅回撤，ADC有「泡沫」？英派藥業遞表港交所，今年上半年淨虧損1.29億元 | 掘金創新藥

每日经济新闻

長春高新「作繭自縛」

中國生物製藥(01177)：LM-350「CDH17 ADC」完成澳洲I期臨牀首例患者入組

中國ADC「出海」潮迭起：下一個百億重磅交易在哪？

21世纪经济报道

雙抗ADC崛起，百奧賽圖為代表的中國Biotech機會

百奧賽圖在雙抗ADC崛起時代的關鍵賦能

「ADC+小分子」組合療法升温，百奧賽圖再獲全球資本青睞

百奧賽圖的「破局密碼」：從模式動物到ADC全球合作

百奧賽圖：從「千鼠萬抗」到全球合作，中國Biotech的出海範本

長城基金譚小兵：三重邏輯驅動創新藥看好ADC等細分領域

百奧賽圖「雙業務線」持續放量：多項國際合作開啓新階段

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/ADC/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"艾格里房產","latestPrice":74.8,"timestamp":1761336000000,"preClose":75.14,"halted":0,"volume":1060738,"hourTrading":{"tag":"盘后","latestPrice":74.8,"preClose":74.8,"latestTime":"19:14 EDT","volume":29322,"amount":2193332.55,"timestamp":1761347668391},"delay":0,"floatShares":108366822,"shares":114934390,"eps":1.712089,"marketStatus":"休市中","change":-0.34,"latestTime":"10-24 16:00:00 EDT","open":75.14,"high":75.885,"low":74.69,"amount":79730461.93273,"amplitude":0.015904,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.712089,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1761552000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":75.14,"dividendRate":0.040829,"preHourTrading":{"tag":"盘前","latestPrice":75.14,"preClose":75.14,"latestTime":"08:02 EDT","volume":8,"amount":588.95,"timestamp":1761307341238},"postHourTrading":{"tag":"盘后","latestPrice":74.8,"preClose":74.8,"latestTime":"19:14 EDT","volume":29322,"amount":2193332.55,"timestamp":1761347668391},"volumeRatio":0.8038027670558262,"impliedVol":0.1989,"impliedVolPercentile":0.2},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADC\",,,,,undefined,":{"symbol":"ADC","floatShares":108366822,"roa":"2.33%","roe":"3.48%","lyrEps":1.793039,"volumeRatio":0.8038027670558262,"shares":114934390,"dividePrice":3.054,"high":75.885,"amplitude":0.015904,"preClose":75.14,"low":74.69,"week52Low":67.58,"pbRate":"1.51","psRate":"12.48","week52High":79.65,"institutionHeld":0.9901,"latestPrice":74.8,"eps":1.712089,"divideRate":0.040829,"volume":1060738,"delay":0,"ttmEps":1.712089,"open":75.14,"prevYearClose":70.45,"prevWeekClose":75.06,"prevMonthClose":71.04,"prevQuarterClose":71.04,"fiveDayClose":75.06,"twentyDayClose":71.26,"sixtyDayClose":71.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADC\",params:#limit:5,,,undefined,":[{"date":"2025-10-31","symbol":"ADC","amount":0.262,"announcedDate":"2025-10-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-10-31","defaultRemindTime":1761917400000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-11-14","payableDate":"2025-10-31","currency":"USD","dateTimestamp":1761883200000,"payDate":"2025-11-14"},{"date":"2025-10-21","symbol":"ADC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":1.05,"defaultRemindTime":1761076800000,"name":null,"time":"盤後","dateTimestamp":1761019200000,"actualEps":1.03},{"date":"2025-09-30","symbol":"ADC","amount":0.256,"announcedDate":"2025-09-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-30","defaultRemindTime":1759239000000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-14","payableDate":"2025-09-30","currency":"USD","dateTimestamp":1759204800000,"payDate":"2025-10-14"},{"date":"2025-08-29","symbol":"ADC","amount":0.256,"announcedDate":"2025-08-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-29","defaultRemindTime":1756474200000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-15","payableDate":"2025-08-29","currency":"USD","dateTimestamp":1756440000000,"payDate":"2025-09-15"},{"date":"2025-07-31","symbol":"ADC","amount":0.256,"announcedDate":"2025-07-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-31","defaultRemindTime":1753968600000,"name":"艾格里房产","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-14","payableDate":"2025-07-31","currency":"USD","dateTimestamp":1753934400000,"payDate":"2025-08-14"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADC\",market:\"US\",,,undefined,":[{"executeDate":"2015-12-18","recordDate":"2015-12-22","paymentDate":"2016-01-05","value":0.465,"currency":"USD"},{"executeDate":"2016-03-29","recordDate":"2016-03-31","paymentDate":"2016-04-15","value":0.465,"currency":"USD"},{"executeDate":"2016-06-28","recordDate":"2016-06-30","paymentDate":"2016-07-15","value":0.48,"currency":"USD"},{"executeDate":"2016-09-28","recordDate":"2016-09-30","paymentDate":"2016-10-14","value":0.48,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2017-01-03","value":0.495,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.381,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.381,"analysts":21,"updateTime":1752206400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADC","date":"2025-10-24","current":43.689318,"percent":0.792345,"low":31.539495,"twenty":37.639342,"median":41.220151,"eighty":44.656944,"high":53.261716,"avg":41.272428,"sd":4.471176,"marketCap":8621592904},"quantilePoints":[{"date":"2020-10-30","current":38.164301,"twenty":31.975443,"median":37.733323,"eighty":43.037844,"marketCap":3447190528},{"date":"2020-11-06","current":38.797606,"twenty":31.975443,"median":37.935059,"eighty":43.037844,"marketCap":3504393786},{"date":"2020-11-13","current":41.26934,"twenty":31.975443,"median":38.046028,"eighty":43.037844,"marketCap":3727653105},{"date":"2020-11-20","current":40.039622,"twenty":31.975443,"median":38.167733,"eighty":43.037844,"marketCap":3616578817},{"date":"2020-11-27","current":40.506914,"twenty":31.975443,"median":38.310136,"eighty":43.037844,"marketCap":3658787046},{"date":"2020-12-04","current":40.580698,"twenty":31.975443,"median":38.471704,"eighty":43.037844,"marketCap":3665451504},{"date":"2020-12-11","current":40.230228,"twenty":31.975443,"median":38.545534,"eighty":43.037844,"marketCap":3633795331},{"date":"2020-12-18","current":39.344831,"twenty":31.975443,"median":38.676992,"eighty":43.037844,"marketCap":3553821844},{"date":"2020-12-24","current":39.762935,"twenty":31.975443,"median":38.782235,"eighty":43.037844,"marketCap":3591587102},{"date":"2020-12-31","current":40.937316,"twenty":31.975443,"median":38.892751,"eighty":43.037844,"marketCap":3697663047},{"date":"2021-01-08","current":45.450661,"twenty":31.975443,"median":39.008592,"eighty":43.047885,"marketCap":4105330986},{"date":"2021-01-15","current":44.653159,"twenty":31.975443,"median":39.245492,"eighty":43.22631,"marketCap":4033296550},{"date":"2021-01-22","current":45.359718,"twenty":31.975443,"median":39.341757,"eighty":43.313411,"marketCap":4097116533},{"date":"2021-01-29","current":44.212433,"twenty":31.975443,"median":39.41667,"eighty":43.4163,"marketCap":3993488046},{"date":"2021-02-05","current":46.262155,"twenty":31.975443,"median":39.41667,"eighty":43.554978,"marketCap":4178629185},{"date":"2021-02-12","current":45.520618,"twenty":31.975443,"median":39.41667,"eighty":43.618647,"marketCap":4111649797},{"date":"2021-02-19","current":43.859591,"twenty":31.975443,"median":39.41667,"eighty":43.642628,"marketCap":4007933303},{"date":"2021-02-26","current":44.718497,"twenty":31.977009,"median":39.430911,"eighty":43.756513,"marketCap":4086420942},{"date":"2021-03-05","current":44.656157,"twenty":31.975443,"median":39.41667,"eighty":43.796506,"marketCap":4080724259},{"date":"2021-03-12","current":46.594043,"twenty":31.975443,"median":39.41667,"eighty":43.856021,"marketCap":4257810284},{"date":"2021-03-19","current":46.240217,"twenty":31.975443,"median":39.41667,"eighty":43.889974,"marketCap":4225477299},{"date":"2021-03-26","current":46.69811,"twenty":31.977009,"median":39.430911,"eighty":43.995818,"marketCap":4267319985},{"date":"2021-04-01","current":47.239256,"twenty":31.977009,"median":39.430911,"eighty":44.083322,"marketCap":4316770432},{"date":"2021-04-09","current":47.1005,"twenty":31.975443,"median":39.41667,"eighty":44.146464,"marketCap":4304090831},{"date":"2021-04-16","current":47.627771,"twenty":31.975443,"median":39.41667,"eighty":44.201737,"marketCap":4352273317},{"date":"2021-04-23","current":49.334461,"twenty":31.975443,"median":39.41667,"eighty":44.216631,"marketCap":4508232419},{"date":"2021-04-30","current":48.814129,"twenty":31.975443,"median":39.41667,"eighty":44.274005,"marketCap":4460683913},{"date":"2021-05-07","current":44.881383,"twenty":31.975443,"median":39.41667,"eighty":44.314742,"marketCap":4499986938},{"date":"2021-05-14","current":44.377456,"twenty":31.975443,"median":39.41667,"eighty":44.249425,"marketCap":4449461218},{"date":"2021-05-21","current":44.026621,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4414285084},{"date":"2021-05-28","current":44.830352,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4494870410},{"date":"2021-06-04","current":45.665977,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4578653566},{"date":"2021-06-11","current":45.646841,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4576734868},{"date":"2021-06-18","current":47.246871,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4737160278},{"date":"2021-06-25","current":48.748389,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4887708512},{"date":"2021-07-02","current":48.211648,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4833892628},{"date":"2021-07-09","current":49.210395,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":4934031046},{"date":"2021-07-16","current":49.93058,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5006239701},{"date":"2021-07-23","current":50.956505,"twenty":31.977009,"median":39.430911,"eighty":44.196388,"marketCap":5109102975},{"date":"2021-07-30","current":53.056971,"twenty":31.977009,"median":39.430911,"eighty":44.230599,"marketCap":5165308396},{"date":"2021-08-06","current":52.598062,"twenty":31.977009,"median":39.430911,"eighty":44.296692,"marketCap":5120631744},{"date":"2021-08-13","current":52.520401,"twenty":31.977009,"median":39.430911,"eighty":44.412506,"marketCap":5113071079},{"date":"2021-08-20","current":52.718085,"twenty":31.977009,"median":39.430911,"eighty":44.625208,"marketCap":5132316407},{"date":"2021-08-27","current":52.209754,"twenty":31.977009,"median":39.430911,"eighty":44.658936,"marketCap":5082828422},{"date":"2021-09-03","current":52.675724,"twenty":31.977009,"median":39.430911,"eighty":44.712504,"marketCap":5128192408},{"date":"2021-09-10","current":49.555141,"twenty":31.977009,"median":39.430911,"eighty":44.74795,"marketCap":4824391169},{"date":"2021-09-17","current":50.119952,"twenty":31.977009,"median":39.430911,"eighty":44.835833,"marketCap":4879377818},{"date":"2021-09-24","current":47.775985,"twenty":31.977009,"median":39.430911,"eighty":44.888065,"marketCap":4651183223},{"date":"2021-10-01","current":47.352376,"twenty":31.977009,"median":39.430911,"eighty":44.941549,"marketCap":4609943235},{"date":"2021-10-08","current":47.670083,"twenty":31.977009,"median":39.430911,"eighty":44.9864,"marketCap":4640873226},{"date":"2021-10-15","current":49.02563,"twenty":31.977009,"median":39.430911,"eighty":45.094688,"marketCap":4772841185},{"date":"2021-10-22","current":49.5269,"twenty":31.977009,"median":39.430911,"eighty":45.190701,"marketCap":4821641836},{"date":"2021-10-29","current":50.169373,"twenty":32.013133,"median":39.571166,"eighty":45.28245,"marketCap":4884189150},{"date":"2021-11-05","current":43.773853,"twenty":32.013133,"median":39.651928,"eighty":45.28245,"marketCap":4934976633},{"date":"2021-11-12","current":43.137928,"twenty":32.029424,"median":39.72736,"eighty":45.28245,"marketCap":4863283742},{"date":"2021-11-19","current":43.008274,"twenty":32.198132,"median":39.802558,"eighty":45.28245,"marketCap":4848666745},{"date":"2021-11-26","current":42.662528,"twenty":32.27459,"median":39.842867,"eighty":45.28245,"marketCap":4809688086},{"date":"2021-12-03","current":42.508177,"twenty":32.348817,"median":39.911012,"eighty":45.28245,"marketCap":4792286899},{"date":"2021-12-10","current":42.891493,"twenty":32.447032,"median":39.953188,"eighty":45.28245,"marketCap":4835501148},{"date":"2021-12-17","current":45.380751,"twenty":32.521786,"median":39.996581,"eighty":45.380751,"marketCap":5116135105},{"date":"2021-12-23","current":46.352906,"twenty":32.588031,"median":40.079057,"eighty":45.406143,"marketCap":5225733953},{"date":"2021-12-31","current":48.175698,"twenty":32.64443,"median":40.10618,"eighty":45.47788,"marketCap":5431231792},{"date":"2022-01-07","current":46.703962,"twenty":32.651599,"median":40.164071,"eighty":45.565296,"marketCap":5265311314},{"date":"2022-01-14","current":46.015352,"twenty":32.70478,"median":40.208708,"eighty":45.667046,"marketCap":5187678797},{"date":"2022-01-21","current":43.267663,"twenty":32.731462,"median":40.224323,"eighty":45.667046,"marketCap":4877909831},{"date":"2022-01-28","current":43.821252,"twenty":32.743358,"median":40.249944,"eighty":45.667046,"marketCap":4940320287},{"date":"2022-02-04","current":42.666817,"twenty":32.769192,"median":40.314701,"eighty":45.667046,"marketCap":4810171655},{"date":"2022-02-11","current":42.565551,"twenty":32.769192,"median":40.347561,"eighty":45.667046,"marketCap":4798755108},{"date":"2022-02-18","current":42.943612,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4841376882},{"date":"2022-02-25","current":37.784604,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4620036905},{"date":"2022-03-04","current":38.267307,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4679058463},{"date":"2022-03-11","current":37.29027,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4559593141},{"date":"2022-03-18","current":37.24956,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4554615419},{"date":"2022-03-25","current":38.110019,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4659826391},{"date":"2022-04-01","current":39.298046,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4805089927},{"date":"2022-04-08","current":39.763938,"twenty":32.769192,"median":40.395099,"eighty":45.667046,"marketCap":4862056020},{"date":"2022-04-14","current":40.742313,"twenty":32.769192,"median":40.404479,"eighty":45.667046,"marketCap":4981684815},{"date":"2022-04-22","current":42.01187,"twenty":32.769192,"median":40.455317,"eighty":45.667046,"marketCap":5136917418},{"date":"2022-04-29","current":39.554287,"twenty":32.79826,"median":40.479695,"eighty":45.667046,"marketCap":4836421278},{"date":"2022-05-06","current":39.499614,"twenty":32.904642,"median":40.479695,"eighty":45.667046,"marketCap":5066773466},{"date":"2022-05-13","current":39.967203,"twenty":32.996397,"median":40.479695,"eighty":45.667046,"marketCap":5126753027},{"date":"2022-05-20","current":39.90291,"twenty":33.05702,"median":40.479695,"eighty":45.667046,"marketCap":5118505838},{"date":"2022-05-27","current":40.353768,"twenty":33.088236,"median":40.495181,"eighty":45.667046,"marketCap":5176339242},{"date":"2022-06-03","current":40.599257,"twenty":33.156377,"median":40.53176,"eighty":45.667046,"marketCap":5207829139},{"date":"2022-06-10","current":41.119461,"twenty":33.227354,"median":40.613635,"eighty":45.667046,"marketCap":5274557730},{"date":"2022-06-17","current":40.213488,"twenty":33.270165,"median":40.613635,"eighty":45.667046,"marketCap":5158345016},{"date":"2022-06-24","current":43.32302,"twenty":33.260026,"median":40.659236,"eighty":45.668114,"marketCap":5557217043},{"date":"2022-07-01","current":42.978166,"twenty":33.330747,"median":40.684242,"eighty":45.668114,"marketCap":5512981235},{"date":"2022-07-08","current":42.872956,"twenty":33.466784,"median":40.715658,"eighty":45.668114,"marketCap":5499485565},{"date":"2022-07-15","current":43.708789,"twenty":33.59929,"median":40.742313,"eighty":45.668114,"marketCap":5606701167},{"date":"2022-07-22","current":44.556311,"twenty":33.59929,"median":40.778643,"eighty":45.668114,"marketCap":5715416287},{"date":"2022-07-29","current":46.520226,"twenty":33.675236,"median":40.820493,"eighty":45.678143,"marketCap":5967335462},{"date":"2022-08-05","current":43.100932,"twenty":33.675236,"median":40.862996,"eighty":45.68777,"marketCap":6116022220},{"date":"2022-08-12","current":44.318758,"twenty":33.675236,"median":40.912721,"eighty":45.68777,"marketCap":6288831702},{"date":"2022-08-19","current":44.509569,"twenty":33.675236,"median":40.969109,"eighty":45.68777,"marketCap":6315907842},{"date":"2022-08-26","current":43.241234,"twenty":33.675236,"median":41.010201,"eighty":45.68777,"marketCap":6135931147},{"date":"2022-09-02","current":41.585665,"twenty":33.675236,"median":41.060268,"eighty":45.68777,"marketCap":5901005814},{"date":"2022-09-09","current":41.956063,"twenty":33.675236,"median":41.092655,"eighty":45.68777,"marketCap":5953565380},{"date":"2022-09-16","current":40.805583,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5790312183},{"date":"2022-09-23","current":39.935707,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5666876838},{"date":"2022-09-30","current":37.927001,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5381841428},{"date":"2022-10-07","current":36.428553,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5169211706},{"date":"2022-10-14","current":35.631626,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5056127734},{"date":"2022-10-21","current":36.636203,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5198677248},{"date":"2022-10-28","current":38.359137,"twenty":33.675236,"median":41.109476,"eighty":45.68777,"marketCap":5443161610},{"date":"2022-11-04","current":41.724424,"twenty":33.675236,"median":41.119461,"eighty":45.68777,"marketCap":6035896875},{"date":"2022-11-11","current":42.347632,"twenty":33.675236,"median":41.160749,"eighty":45.68777,"marketCap":6126050848},{"date":"2022-11-18","current":42.756995,"twenty":33.675236,"median":41.197005,"eighty":45.68777,"marketCap":6185269635},{"date":"2022-11-25","current":43.056379,"twenty":33.675236,"median":41.218321,"eighty":45.68777,"marketCap":6228578896},{"date":"2022-12-02","current":43.196907,"twenty":33.675236,"median":41.257018,"eighty":45.68777,"marketCap":6248907733},{"date":"2022-12-09","current":43.795676,"twenty":33.675236,"median":41.35326,"eighty":45.68777,"marketCap":6335526256},{"date":"2022-12-16","current":43.172467,"twenty":33.675236,"median":41.423201,"eighty":45.68777,"marketCap":6245372283},{"date":"2022-12-23","current":43.685698,"twenty":33.675236,"median":41.463369,"eighty":45.68777,"marketCap":6319616732},{"date":"2022-12-30","current":43.337434,"twenty":33.675236,"median":41.483593,"eighty":45.68777,"marketCap":6269236570},{"date":"2023-01-06","current":43.245786,"twenty":34.167053,"median":41.539601,"eighty":45.68777,"marketCap":6255978633},{"date":"2023-01-13","current":45.714181,"twenty":34.992765,"median":41.587683,"eighty":45.704396,"marketCap":6613059075},{"date":"2023-01-20","current":45.402576,"twenty":35.880519,"median":41.605991,"eighty":45.714503,"marketCap":6567982088},{"date":"2023-01-27","current":45.378137,"twenty":36.169649,"median":41.646285,"eighty":45.714503,"marketCap":6564446638},{"date":"2023-02-03","current":45.255939,"twenty":36.592515,"median":41.674422,"eighty":45.714503,"marketCap":6546769389},{"date":"2023-02-10","current":44.406665,"twenty":36.713651,"median":41.711398,"eighty":45.714503,"marketCap":6423912504},{"date":"2023-02-17","current":44.157808,"twenty":36.89773,"median":41.739833,"eighty":45.714503,"marketCap":6731283715},{"date":"2023-02-24","current":42.410386,"twenty":36.963658,"median":41.754028,"eighty":45.714503,"marketCap":6464912060},{"date":"2023-03-03","current":41.690165,"twenty":37.214665,"median":41.783816,"eighty":45.714503,"marketCap":6355123742},{"date":"2023-03-10","current":39.423241,"twenty":37.286636,"median":41.783816,"eighty":45.714503,"marketCap":6009560514},{"date":"2023-03-17","current":40.355986,"twenty":37.342014,"median":41.783816,"eighty":45.714503,"marketCap":6151745384},{"date":"2023-03-24","current":39.606247,"twenty":37.466803,"median":41.783816,"eighty":45.714503,"marketCap":6037457546},{"date":"2023-03-31","current":40.621801,"twenty":37.536428,"median":41.78137,"eighty":45.714342,"marketCap":6192265465},{"date":"2023-04-06","current":39.692254,"twenty":37.577737,"median":41.783816,"eighty":45.714503,"marketCap":6050568092},{"date":"2023-04-14","current":39.289647,"twenty":37.687654,"median":41.784219,"eighty":45.714663,"marketCap":5989195981},{"date":"2023-04-21","current":39.792905,"twenty":37.872566,"median":41.784621,"eighty":45.714824,"marketCap":6065911119},{"date":"2023-04-28","current":40.118543,"twenty":37.943837,"median":41.797292,"eighty":45.714985,"marketCap":6115550327},{"date":"2023-05-05","current":39.964605,"twenty":38.110019,"median":41.797292,"eighty":45.714985,"marketCap":6092084520},{"date":"2023-05-12","current":39.104119,"twenty":38.249787,"median":41.797292,"eighty":45.714985,"marketCap":6176026400},{"date":"2023-05-19","current":38.898029,"twenty":38.342909,"median":41.797292,"eighty":45.714985,"marketCap":6143476946},{"date":"2023-05-26","current":37.796919,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5969569863},{"date":"2023-06-02","current":37.832249,"twenty":38.456408,"median":41.797292,"eighty":45.714985,"marketCap":5975149770},{"date":"2023-06-09","current":38.668386,"twenty":38.476762,"median":41.797292,"eighty":45.714985,"marketCap":6107207554},{"date":"2023-06-16","current":38.786152,"twenty":38.533217,"median":41.797292,"eighty":45.714985,"marketCap":6125807242},{"date":"2023-06-23","current":38.509402,"twenty":38.553397,"median":41.809962,"eighty":45.718688,"marketCap":6082097976},{"date":"2023-06-30","current":38.55062,"twenty":38.5799,"median":41.81327,"eighty":45.72239,"marketCap":6088607866},{"date":"2023-07-07","current":38.662498,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6106277570},{"date":"2023-07-14","current":38.603615,"twenty":38.628346,"median":41.81327,"eighty":45.72239,"marketCap":6096977726},{"date":"2023-07-21","current":39.357316,"twenty":38.659115,"median":41.81327,"eighty":45.72239,"marketCap":6216015729},{"date":"2023-07-28","current":39.404422,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6223455604},{"date":"2023-08-04","current":38.053978,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6196443469},{"date":"2023-08-11","current":37.511193,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":6108060089},{"date":"2023-08-18","current":36.166029,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5889023018},{"date":"2023-08-25","current":36.531819,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5948585730},{"date":"2023-09-01","current":36.472821,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5938978841},{"date":"2023-09-08","current":35.75304,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5821774794},{"date":"2023-09-15","current":35.446248,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5771818971},{"date":"2023-09-22","current":33.711695,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5489376431},{"date":"2023-09-29","current":32.567126,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5303002783},{"date":"2023-10-06","current":32.649724,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5316452427},{"date":"2023-10-13","current":31.806046,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5179073913},{"date":"2023-10-20","current":32.41963,"twenty":38.699097,"median":41.81327,"eighty":45.72239,"marketCap":5278985560},{"date":"2023-10-27","current":33.181375,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5472604212},{"date":"2023-11-03","current":35.377246,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5834769220},{"date":"2023-11-10","current":34.598655,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5706356142},{"date":"2023-11-17","current":35.425908,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5842795038},{"date":"2023-11-24","current":35.170433,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5800659496},{"date":"2023-12-01","current":36.015934,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":5940108073},{"date":"2023-12-08","current":36.873602,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6081563104},{"date":"2023-12-15","current":37.7556,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6227031044},{"date":"2023-12-22","current":37.968496,"twenty":38.730653,"median":41.843819,"eighty":45.729795,"marketCap":6262143995},{"date":"2023-12-29","current":38.607184,"twenty":38.744189,"median":41.871061,"eighty":45.733498,"marketCap":6367482847},{"date":"2024-01-05","current":38.296964,"twenty":38.756995,"median":41.871582,"eighty":45.73451,"marketCap":6316318262},{"date":"2024-01-12","current":38.090151,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":6282208538},{"date":"2024-01-19","current":36.989174,"twenty":38.764196,"median":41.872103,"eighty":45.735522,"marketCap":6100624420},{"date":"2024-01-26","current":36.295741,"twenty":38.758791,"median":41.871582,"eighty":45.73451,"marketCap":5986256523},{"date":"2024-02-02","current":37.232484,"twenty":38.697827,"median":41.871582,"eighty":45.73451,"marketCap":6140753507},{"date":"2024-02-09","current":35.261674,"twenty":38.661168,"median":41.871582,"eighty":45.73451,"marketCap":5815707904},{"date":"2024-02-16","current":33.847315,"twenty":38.629468,"median":41.871582,"eighty":45.73451,"marketCap":5752655855},{"date":"2024-02-23","current":33.670228,"twenty":38.597685,"median":41.871582,"eighty":45.73451,"marketCap":5722558249},{"date":"2024-03-01","current":32.436519,"twenty":38.556509,"median":41.871061,"eighty":45.733498,"marketCap":5512878257},{"date":"2024-03-08","current":33.758772,"twenty":38.535146,"median":41.871061,"eighty":45.733498,"marketCap":5737607052},{"date":"2024-03-15","current":32.6018,"twenty":38.489062,"median":41.871061,"eighty":45.733498,"marketCap":5540969356},{"date":"2024-03-22","current":33.262927,"twenty":38.456408,"median":41.871061,"eighty":45.733498,"marketCap":5653333754},{"date":"2024-03-28","current":33.457723,"twenty":38.385748,"median":41.784621,"eighty":45.733498,"marketCap":5686441121},{"date":"2024-04-05","current":33.192092,"twenty":38.338315,"median":41.766476,"eighty":45.73451,"marketCap":5641294711},{"date":"2024-04-12","current":33.499043,"twenty":38.271415,"median":41.746116,"eighty":45.73451,"marketCap":5693463896},{"date":"2024-04-19","current":32.99201,"twenty":38.226469,"median":41.73308,"eighty":45.73451,"marketCap":5607289064},{"date":"2024-04-26","current":33.647761,"twenty":38.150217,"median":41.720309,"eighty":45.733498,"marketCap":5827926731},{"date":"2024-05-03","current":33.618779,"twenty":38.090151,"median":41.711398,"eighty":45.733498,"marketCap":5822906984},{"date":"2024-05-10","current":34.482434,"twenty":38.029323,"median":41.69585,"eighty":45.733498,"marketCap":5972495456},{"date":"2024-05-17","current":34.986715,"twenty":37.950247,"median":41.66791,"eighty":45.733498,"marketCap":6059839061},{"date":"2024-05-24","current":34.198413,"twenty":37.871294,"median":41.619337,"eighty":45.733498,"marketCap":5923301932},{"date":"2024-05-31","current":34.928752,"twenty":37.820473,"median":41.602226,"eighty":45.733498,"marketCap":6049799566},{"date":"2024-06-07","current":35.908334,"twenty":37.7418,"median":41.585665,"eighty":45.733498,"marketCap":6219467028},{"date":"2024-06-14","current":35.311311,"twenty":37.642264,"median":41.478607,"eighty":45.73451,"marketCap":6116060232},{"date":"2024-06-21","current":35.485201,"twenty":37.563829,"median":41.447441,"eighty":45.735522,"marketCap":6146178716},{"date":"2024-06-28","current":35.734443,"twenty":37.537078,"median":41.447441,"eighty":45.738558,"marketCap":6189348544},{"date":"2024-07-05","current":35.879352,"twenty":37.482188,"median":41.447441,"eighty":45.738558,"marketCap":6214447281},{"date":"2024-07-12","current":36.957471,"twenty":37.418215,"median":41.439295,"eighty":45.738558,"marketCap":6401181884},{"date":"2024-07-15","current":37.189325,"twenty":37.412399,"median":41.439295,"eighty":45.738558,"marketCap":6441339863},{"date":"2024-08-02","current":37.993919,"twenty":37.339153,"median":41.40142,"eighty":45.707657,"marketCap":7107142493},{"date":"2024-08-09","current":38.417922,"twenty":37.339153,"median":41.351038,"eighty":45.669183,"marketCap":7186456557},{"date":"2024-08-16","current":38.455492,"twenty":37.339153,"median":41.248609,"eighty":45.587895,"marketCap":7193484385},{"date":"2024-08-23","current":38.879496,"twenty":37.339153,"median":41.197005,"eighty":45.51208,"marketCap":7272798449},{"date":"2024-08-30","current":39.104915,"twenty":37.339153,"median":41.152223,"eighty":45.432939,"marketCap":7314965420},{"date":"2024-09-06","current":40.19981,"twenty":37.339153,"median":41.109476,"eighty":45.406991,"marketCap":7519776420},{"date":"2024-09-13","current":40.725789,"twenty":37.339153,"median":41.060268,"eighty":45.379705,"marketCap":7618166018},{"date":"2024-09-20","current":39.786541,"twenty":37.339153,"median":41.020981,"eighty":45.296882,"marketCap":7442470307},{"date":"2024-09-27","current":39.931453,"twenty":37.339153,"median":40.992653,"eighty":45.271719,"marketCap":7469577645},{"date":"2024-10-04","current":40.355457,"twenty":37.339153,"median":40.937316,"eighty":45.211095,"marketCap":7548891709},{"date":"2024-10-11","current":39.3196,"twenty":37.339153,"median":40.894276,"eighty":45.159517,"marketCap":7355124439},{"date":"2024-10-18","current":40.731156,"twenty":37.339153,"median":40.838938,"eighty":45.089028,"marketCap":7619169993},{"date":"2024-10-25","current":42.532506,"twenty":37.339153,"median":40.820493,"eighty":45.046981,"marketCap":8077475775},{"date":"2024-10-31","current":40.816625,"twenty":37.339153,"median":40.816625,"eighty":44.988744,"marketCap":7751607762},{"date":"2024-11-08","current":40.076878,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7611120201},{"date":"2024-11-15","current":41.115788,"twenty":37.338438,"median":40.773001,"eighty":44.942004,"marketCap":7808422584},{"date":"2024-11-22","current":41.948003,"twenty":37.338438,"median":40.773001,"eighty":44.914929,"marketCap":7966471090},{"date":"2024-11-29","current":41.773945,"twenty":37.338438,"median":40.773001,"eighty":44.914324,"marketCap":7933415193},{"date":"2024-12-06","current":40.849261,"twenty":37.338438,"median":40.770318,"eighty":44.892115,"marketCap":7757805742},{"date":"2024-12-13","current":40.055121,"twenty":37.338438,"median":40.736734,"eighty":44.892115,"marketCap":7606988214},{"date":"2024-12-20","current":37.770608,"twenty":37.338438,"median":40.680888,"eighty":44.892115,"marketCap":7173129570},{"date":"2024-12-27","current":38.515795,"twenty":37.338438,"median":40.640959,"eighty":44.892115,"marketCap":7314650128},{"date":"2025-01-03","current":37.933788,"twenty":37.338438,"median":40.614232,"eighty":44.892115,"marketCap":7204119473},{"date":"2025-01-10","current":37.906591,"twenty":37.337724,"median":40.580698,"eighty":44.89414,"marketCap":7198954490},{"date":"2025-01-17","current":39.244663,"twenty":37.333873,"median":40.538993,"eighty":44.89414,"marketCap":7453071695},{"date":"2025-01-24","current":38.87479,"twenty":37.333873,"median":40.501145,"eighty":44.89414,"marketCap":7382827915},{"date":"2025-01-31","current":39.761398,"twenty":37.333873,"median":40.465332,"eighty":44.84311,"marketCap":7551206388},{"date":"2025-02-07","current":39.74508,"twenty":37.333873,"median":40.424995,"eighty":44.718497,"marketCap":7548107398},{"date":"2025-02-14","current":40.634976,"twenty":37.333873,"median":40.403761,"eighty":44.67404,"marketCap":7688015540},{"date":"2025-02-21","current":40.363435,"twenty":37.333873,"median":40.374953,"eighty":44.653159,"marketCap":7636640801},{"date":"2025-02-28","current":41.687197,"twenty":37.333873,"median":40.374953,"eighty":44.559412,"marketCap":7887092651},{"date":"2025-03-07","current":42.394335,"twenty":37.33306,"median":40.37194,"eighty":44.562299,"marketCap":8020881032},{"date":"2025-03-14","current":42.767704,"twenty":37.33306,"median":40.383179,"eighty":44.562299,"marketCap":8091521298},{"date":"2025-03-21","current":43.141073,"twenty":37.417052,"median":40.40791,"eighty":44.562299,"marketCap":8162161563},{"date":"2025-03-28","current":42.993988,"twenty":37.479862,"median":40.452151,"eighty":44.562299,"marketCap":8134333580},{"date":"2025-04-04","current":43.440899,"twenty":37.536428,"median":40.487288,"eighty":44.562299,"marketCap":8218887836},{"date":"2025-04-11","current":41.268572,"twenty":37.537078,"median":40.501145,"eighty":44.559412,"marketCap":7807889929},{"date":"2025-04-17","current":44.145605,"twenty":37.540692,"median":40.519212,"eighty":44.559412,"marketCap":8352216066},{"date":"2025-04-25","current":43.782817,"twenty":37.571542,"median":40.572736,"eighty":44.653759,"marketCap":8377141546},{"date":"2025-05-02","current":45.953462,"twenty":37.571542,"median":40.583839,"eighty":44.677947,"marketCap":8792459672},{"date":"2025-05-09","current":43.031008,"twenty":37.571542,"median":40.598117,"eighty":44.677947,"marketCap":8233294969},{"date":"2025-05-16","current":42.422675,"twenty":37.571542,"median":40.624906,"eighty":44.677947,"marketCap":8116900028},{"date":"2025-05-23","current":42.755537,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8180587826},{"date":"2025-05-30","current":42.698147,"twenty":37.571542,"median":40.666871,"eighty":44.677947,"marketCap":8169607171},{"date":"2025-06-06","current":42.411197,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8114703897},{"date":"2025-06-13","current":42.927706,"twenty":37.571542,"median":40.666871,"eighty":44.666838,"marketCap":8213529790},{"date":"2025-06-20","current":43.220395,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8269531129},{"date":"2025-06-27","current":41.894687,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":8015878004},{"date":"2025-07-03","current":41.30357,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7902777259},{"date":"2025-07-11","current":40.735409,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7794068777},{"date":"2025-07-18","current":41.234702,"twenty":37.563829,"median":40.663552,"eighty":44.606841,"marketCap":7889600473},{"date":"2025-07-25","current":42.319373,"twenty":37.604201,"median":40.725789,"eighty":44.606841,"marketCap":8097134849},{"date":"2025-08-01","current":42.372392,"twenty":37.604201,"median":40.742491,"eighty":44.606841,"marketCap":7873129491},{"date":"2025-08-08","current":43.918584,"twenty":37.604201,"median":40.752858,"eighty":44.633348,"marketCap":8160424292},{"date":"2025-08-15","current":42.901923,"twenty":37.604201,"median":40.790693,"eighty":44.633348,"marketCap":7971520467},{"date":"2025-08-22","current":44.019656,"twenty":37.604201,"median":40.820493,"eighty":44.633348,"marketCap":8179204204},{"date":"2025-08-29","current":43.199192,"twenty":37.604201,"median":40.894276,"eighty":44.633348,"marketCap":8026755504},{"date":"2025-09-05","current":42.806797,"twenty":37.595885,"median":40.935905,"eighty":44.639951,"marketCap":7953845256},{"date":"2025-09-12","current":43.841294,"twenty":37.604201,"median":40.969944,"eighty":44.633348,"marketCap":8146063183},{"date":"2025-09-19","current":42.527363,"twenty":37.604201,"median":41.008406,"eighty":44.633348,"marketCap":7901924321},{"date":"2025-09-26","current":41.962551,"twenty":37.639342,"median":41.035693,"eighty":44.633348,"marketCap":7796977752},{"date":"2025-10-03","current":42.027951,"twenty":37.639342,"median":41.102705,"eighty":44.633348,"marketCap":7809129460},{"date":"2025-10-10","current":41.974442,"twenty":37.639342,"median":41.115788,"eighty":44.633348,"marketCap":7799187153},{"date":"2025-10-17","current":44.322871,"twenty":37.639342,"median":41.17126,"eighty":44.633348,"marketCap":8235543942},{"date":"2025-10-24","current":44.544295,"twenty":37.639342,"median":41.220151,"eighty":44.656944,"marketCap":8621592904}],"updateTime":1761532584822},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADC\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575320031","title":"百利天恆(688506.SH)：T-Bren(HER2 ADC)用於在HER2陽性局部晚期或轉移性胃或胃食管結合部腺癌III期臨牀試驗完成首例受試者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2575320031","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575320031?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 17:42","pubTimestamp":1760521343,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百利天恒 发布公告，公司自主研发的创新生物药注射用T-Bren用于在一线抗HER2治疗失败的HER2阳性局部晚期或转移性胃或胃食管结合部腺癌的III期临床试验已于近日完成首例受试者入组。T-Bren是一种靶向HER2的创新型ADC，具有同类最佳潜力，已在临床试验中展示出显著的抗肿瘤功效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355405.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688506","BK4231","91194","BK0239","BK4080","III","BK4134","ADC"],"gpt_icon":0},{"id":"2575405883","title":"中國生物製藥(01177)：TQB2102「HER2雙抗ADC」納入突破性治療藥物程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2575405883","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575405883?lang=zh_tw&edition=fundamental","pubTime":"2025-10-13 19:47","pubTimestamp":1760356076,"startTime":"0","endTime":"0","summary":"TQB2102是一款同时靶向HER2蛋白ECD2及ECD4双非重叠表位的双抗ADC药物，凭借差异化的设计在结肠癌治疗中显示出强效优势。此次TQB2102正式纳入BTD，将加速其上市进程，有望早日惠及患者，重塑HER2 IHC 3+结直肠癌治疗格局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1521","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","BK1191","BK1589","01177","BK1515","ADC","BK4231","BK4080","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2575440287","title":"港股異動 | 映恩生物-B(09606)盤中漲超5% 公司首款ADC有望於年內提交上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=2575440287","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575440287?lang=zh_tw&edition=fundamental","pubTime":"2025-10-13 10:31","pubTimestamp":1760322698,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B盘中涨超5%，截至发稿，涨4.68%，报308.4港元，成交额1.04亿港元。据悉，映恩生物-B的DB-1419在实体瘤临床试验中展现优异疗效，标志着中国企业在双抗ADC领域的技术突破。根据映恩生物-B公告，公司预计2025年递交DB-1303用于子宫内膜癌在美国的上市申请、用于乳腺癌在中国的上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HK0000252152.HKD","HK0000252160.HKD","BK4231","YANG","09606","BK4080","BK4614","HK0000500386.USD","BK1161","ADC","LU2543165471.USD"],"gpt_icon":1},{"id":"2575444962","title":"基石藥業-B(02616)將公佈PD-1/VEGF/CTLA-4三抗I期劑量遞增臨牀數據和ROR1 ADC最新研究設計","url":"https://stock-news.laohu8.com/highlight/detail?id=2575444962","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575444962?lang=zh_tw&edition=fundamental","pubTime":"2025-10-13 08:08","pubTimestamp":1760314120,"startTime":"0","endTime":"0","summary":"智通财经APP讯，基石药业-B 发布公告，2025年欧洲肿瘤内科学会年会即将于2025年10月17日至21日在德国柏林举行。基石药业核心临床管线CS2009进行中的 I期剂量递增临床数据摘要和CS5001进行中的Ib期临床研究设计摘要目前已在 ESMO官网公布。在即将正式召开的ESMO大会上，基石药业将以壁报形式展示CS2009在约70例晚期实体瘤患者中的I期剂量递增临床研究初步数据，这也将是目前已知全球首个关于PD-1/VEGF/CTLA-4三特异性抗体的临床数据发表。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1354045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","LU1169589451.USD","LU1169590202.USD","BK1574","ADC","BK4231","BK1161","02616","BK4023","PD"],"gpt_icon":0},{"id":"2574376924","title":"Macrogenics, Inc.盤中異動 下午盤快速下跌5.43%報1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574376924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574376924?lang=zh_tw&edition=fundamental","pubTime":"2025-10-11 01:08","pubTimestamp":1760116107,"startTime":"0","endTime":"0","summary":"北京时间2025年10月11日01时08分，Macrogenics, Inc.股票出现波动，股价急速下挫5.43%。Macrogenics, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Quoin Pharmaceuticals Ltd、Protagonist Therapeutics, Inc.、Gyre Therapeutics, Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aditxt, Inc.、Cdt Equity Inc.较为活跃，换手率分别为1622.31%、348.05%、98.65%，振幅较大的相关个股有Quoin Pharmaceuticals Ltd、Protagonist Therapeutics, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为368.75%、41.02%、40.00%。Macrogenics, Inc.公司简介：Macrogenics Inc是一家生物技术公司，专注于发现和开发用于治疗癌症的基于抗体的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251011010828a6b33d15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251011010828a6b33d15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MGNX","ADC","BK4139","BK4080","BK4231"],"gpt_icon":0},{"id":"2574179662","title":"禮來(LLY.US)FRα ADC啓動III期臨牀研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2574179662","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574179662?lang=zh_tw&edition=fundamental","pubTime":"2025-10-10 20:54","pubTimestamp":1760100849,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月9日，全球临床试验收录网站显示，礼来启动了FRα ADC药物LY4170156的首个III期临床试验。LY4170156是Mablink Bioscience开发的一款FRα ADC药物，其有效载荷为拓扑异构酶I抑制剂依沙替康，DAR值为8。据医药魔方NextPharma数据库统计，目前全球共27款在研FRα ADC药物，其中11款处于临床阶段。除了已经上市的索米妥昔单抗外，Rinatabart sesutecan、BAT8006(百奥泰)和LY4170156是进展最快的3款药物，均已启动III期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1353854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","SG9999015978.USD","LU1061106388.HKD","LU2087625088.SGD","LU0109391861.USD","SG9999001176.USD","LU1551013425.SGD","LU2468319806.SGD","LLY","LU1548497426.USD","LU0432979614.USD","LU0289739699.SGD","LU2357305700.SGD","FR","LU2471134879.HKD","LU2361044949.HKD","LU2237443978.SGD","LU0256863811.USD","LU0456855351.SGD","LU1814569148.SGD","SG9999018865.SGD","LU0096364046.USD","LU0079474960.USD","LU2491050071.SGD","LU2461242641.AUD","LU2237443382.USD","LU0672654240.SGD","LU1280957306.USD","LU0122379950.USD","BK4585","LU2211815571.USD","LU0889565916.HKD","LU0466842654.USD","LU1623119135.USD","LU2417539215.USD","SG9999001176.SGD","LU2106854487.HKD","LU0353189763.USD","SG9999014906.USD","IE00BJT1NW94.SGD","LU1551013342.USD","LU1093756325.SGD","ADC","LU2552382058.USD","SG9999013999.USD","LU1057294990.SGD","LU0471298777.SGD","LU2746668974.SGD","III","BK4171"],"gpt_icon":0},{"id":"2574593124","title":"ADC走到深度競爭時代：三家企業圍着一條管線轉","url":"https://stock-news.laohu8.com/highlight/detail?id=2574593124","media":"钛媒体","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574593124?lang=zh_tw&edition=fundamental","pubTime":"2025-10-10 16:32","pubTimestamp":1760085120,"startTime":"0","endTime":"0","summary":"　　日前，英硅智能、迈威生物、皓元医药这三家分属不同细分领域的企业宣布达成战略合作，共同开拓ADC市场。　　ADC领域涉及到大分子和小分子两种技术的整合。　　皓元医药的ADC业务则是基于其分子砌块业务的积累新开发的领域。仅今年上半年，皓元医药承接的ADC项目数就超过了70个。　　RC48是国内ADC药物领域协同创新的代表作。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2025-10-10/doc-inftkzvh1147989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2574909802","title":"十月開門紅可期，黃金板塊還有戲","url":"https://stock-news.laohu8.com/highlight/detail?id=2574909802","media":"扬子晚报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574909802?lang=zh_tw&edition=fundamental","pubTime":"2025-10-09 07:16","pubTimestamp":1759965371,"startTime":"0","endTime":"0","summary":"多家机构分析认为，十月开门红可期,黄金板块及旅游板块行情或有延续。复宏汉霖拟于条件具备后于中国境内开展该治疗方案的Ib/II期临床试验。截至2025年8月，本集团现阶段针对本次治疗方案的累计研发投入约为人民币15万元。根据中国相关法规要求，本次治疗方案及所涉在研药品均尚处于临床试验阶段，且尚需在中国境内开展一系列临床研究并经国家药品审评部门审批通过后，方可上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009072115a6b122c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009072115a6b122c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2237443382.USD","SH","LU2087625088.SGD","LU0345770308.USD","LU0957808578.USD","LU0444971666.USD","MESmain","LU1280957306.USD","LU2041044095.USD","SPXU","OEX","LU1880398471.USD","LU2272731865.HKD","LU1992135472.HKD","LU2168564495.EUR","LU0234570918.USD","SDS","OEF","BK4559","LU2360108059.USD","LU1323610961.USD","IE00B1XK9C88.USD","LU1670627923.USD",".SPX","LU0787776722.HKD","LU1951198990.SGD","LU2023250504.SGD","IE00BVYPNW00.USD","LU0006306889.USD","LU0320765059.SGD","SSO","ESmain","SG9999015978.USD","BK4550","IVV","ADC","LU1548497426.USD","LU2108987350.USD","LU1145028129.USD","BK4585","SPY","LU0289961442.SGD","UPRO","BK4588","AVGO","LU0672654240.SGD","LU2211814178.USD","LU2250418816.HKD","MU","LU0106261372.USD"],"gpt_icon":1},{"id":"2573939896","title":"第一三共公佈TROPION-Breast02 Ⅲ期研究積極的主要結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2573939896","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573939896?lang=zh_tw&edition=fundamental","pubTime":"2025-10-07 12:19","pubTimestamp":1759810770,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4211","BK4195","BK4080","BK4231","PFS","OS","ADC","BK4097"],"gpt_icon":0},{"id":"2571367489","title":"映恩生物-B大幅回撤，ADC有「泡沫」？英派藥業遞表港交所，今年上半年淨虧損1.29億元 | 掘金創新藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2571367489","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571367489?lang=zh_tw&edition=fundamental","pubTime":"2025-09-30 08:25","pubTimestamp":1759191905,"startTime":"0","endTime":"0","summary":"资本眼一周行情9月22日至9月26日，医药生物指数下跌1.69%，跑输上证指数1.04个百分点。创新药（BK1106）周内下跌2.10%。恒生医疗保健业指数（HSCICH）周下跌2.76%，港股创新药ETF（513120）周内下跌1.60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509303526912423.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509303526912423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["HK0000252152.HKD","LU2543165471.USD","BK1574","BK4231","HK0000500386.USD","HK0000252160.HKD","BK1161","BK4080","ADC","09606","06978"],"gpt_icon":0},{"id":"2571487910","title":"長春高新「作繭自縛」","url":"https://stock-news.laohu8.com/highlight/detail?id=2571487910","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571487910?lang=zh_tw&edition=fundamental","pubTime":"2025-09-29 09:22","pubTimestamp":1759108942,"startTime":"0","endTime":"0","summary":"可能引发一场价值重估","market":"fut","thumbnail":"https://img3.gelonghui.com/73eea-8a796843-f9d5-4d87-938d-9023b17bc426.jpg?guru_height=4480&guru_width=6720&guru_size=2114927","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/73eea-8a796843-f9d5-4d87-938d-9023b17bc426.jpg?guru_height=4480&guru_width=6720&guru_size=2114927"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2922130","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1161","BK0057","BK0239","BK4231","ADC","GD","BK0046","LU0170899867.USD","BK4187","BK4566","BK4550","BK1574","BK4080","BK0028","BK4585","BK4516","000661","06978","BK0188","BK0075","BK4588"],"gpt_icon":0},{"id":"2570930880","title":"中國生物製藥(01177)：LM-350「CDH17 ADC」完成澳洲I期臨牀首例患者入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2570930880","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570930880?lang=zh_tw&edition=fundamental","pubTime":"2025-09-25 18:13","pubTimestamp":1758795215,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，公司全资附属公司礼新医药科技(上海)有限公司自主研发的国家1类创新药LM-350“CDH17抗体偶联药物”在澳洲开展的I期临床试验已顺利完成首例患者入组，标志着这一创新疗法正式进入临床开发阶段。LM-350是基于礼新医药新一代ADC技术平台LM-ADCTM开发的一款靶向CDH17的ADC，能够高度选择性地结合CDH17，具有很强的内化能力。LM-350采用IgG1野生型构型，同时具备抗体依赖细胞介导的细胞毒性作用活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349436.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4231","BK1521","ADC","BK1191","BK1589","IE00BZ08YR35.GBP","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK4080","01177","BK1515"],"gpt_icon":1},{"id":"2569097774","title":"中國ADC「出海」潮迭起：下一個百億重磅交易在哪？","url":"https://stock-news.laohu8.com/highlight/detail?id=2569097774","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569097774?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 17:20","pubTimestamp":1758705610,"startTime":"0","endTime":"0","summary":"2025年，手里缺钱但有管线的中国创新药企，和手里有钱但缺管线的跨国药企，刚好对上了。2025年5月，中国生物医药行业迎来历史性时刻。三生制药宣布与辉瑞达成一笔交易：首付款12.5亿美元，总金额超60亿美元，创下中国创新药出海新纪录。而这仅仅是今年上半年中国抗体药物偶联物（ADC）出海浪潮的一朵浪花。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202509243522532496.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509243522532496.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2569723753","title":"雙抗ADC崛起，百奧賽圖為代表的中國Biotech機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2569723753","media":"新浪证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569723753?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 09:30","pubTimestamp":1758677400,"startTime":"0","endTime":"0","summary":"1913年，德国科学家保罗·埃尔利希提出，要找到一种能够精准打击病灶、不伤害正常细胞的理想药物。一个世纪之后，这一设想在抗体偶联药物上逐渐变为现实。　　ADC通过将单克隆抗体与小分子毒素结合，兼具靶向性与杀伤力，正在深刻改变全球肿瘤治疗的格局。资本的热情同样高涨，仅2025年上半年，ADC领域的对外授权交易金额就接近173亿美元。　　然而，当行业竞争日益激烈，单抗ADC的瓶颈逐渐显现。此时，双特异性抗体偶联药物正悄然崛起。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/hk/2025-09-24/doc-infrqazp9761397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2569772378","title":"百奧賽圖在雙抗ADC崛起時代的關鍵賦能","url":"https://stock-news.laohu8.com/highlight/detail?id=2569772378","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569772378?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 09:29","pubTimestamp":1758677340,"startTime":"0","endTime":"0","summary":"在创新药的全球版图中，抗体偶联药物正在成为最受瞩目的明星赛道。过去五年，Enhertu、Trodelvy等重磅产品点燃了ADC的星火，2024年全球ADC临床试验数达到284项，同比增加逾五成，2025年上半年更有三款新品接连获批。与此同时，资本市场的热情也空前高涨，仅半年间，ADC领域对外授权交易额便接近173亿美元。　　当双抗ADC有望重塑肿瘤治疗格局时，百奥赛图的“王牌时刻”也许才刚刚开始。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/hk/2025-09-24/doc-infrqazp9760634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2569796254","title":"「ADC+小分子」組合療法升温，百奧賽圖再獲全球資本青睞","url":"https://stock-news.laohu8.com/highlight/detail?id=2569796254","media":"新浪证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569796254?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 17:41","pubTimestamp":1758620460,"startTime":"0","endTime":"0","summary":"在全球精准肿瘤治疗赛道上，抗体偶联药物正与小分子药物擦出新的火花。近日，美国精准肿瘤公司IDEAYA Biosciences 在成立十周年研发日上，集中展示了多项研发成果与管线规划，特别引人注目的是两项来自中国的引进项目：恒瑞医药的DLL3 靶向ADC，以及百奥赛图授权的B7-H3/PTK7 双特异性抗体偶联药物。　　这一动作不仅凸显出ADC 热潮下的国际分工，也让“ADC+小分子”这一新兴组合策略成为资本市场和行业的焦点。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/hk/2025-09-23/doc-infrnqyh0505126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2569796649","title":"百奧賽圖的「破局密碼」：從模式動物到ADC全球合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2569796649","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569796649?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 17:36","pubTimestamp":1758620160,"startTime":"0","endTime":"0","summary":"在全球创新药的版图上，抗体偶联药物已被视为“生物导弹”，凭借精准靶向和强效杀伤的双重优势，成为各大药企重点押注的赛道。对中国企业而言，这既是挑战，更是机遇。　　在这一浪潮中，百奥赛图正以独特的技术底座和合作模式，快速进入全球ADC生态。　　截至2025年6月，全球已累计有19款ADC药物获批上市，同时仍有数百个ADC分子处于研发或临床阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/hk/2025-09-23/doc-infrnqyn9122318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4231","BK4080","ADC"],"gpt_icon":0},{"id":"2569628796","title":"百奧賽圖：從「千鼠萬抗」到全球合作，中國Biotech的出海範本","url":"https://stock-news.laohu8.com/highlight/detail?id=2569628796","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569628796?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 17:34","pubTimestamp":1758620040,"startTime":"0","endTime":"0","summary":"在抗体偶联药物热度持续攀升的当下，全球生物医药产业链迎来新一轮重塑。据弗若斯特沙利文预测，到2030年全球ADC外包服务市场规模将达到110亿美元，2022年至2030年的复合年增长率高达28.4%。　　在这条高景气赛道上，国内Biotech正逐步走向全球舞台。百奥赛图便是其中的代表。随着海外合作不断拓展、抗体货架持续放量，公司正在成为中国Biotech出海的典型样本，也为全球新药研发提供了来自东方的创新引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/hk/2025-09-23/doc-infrnqyp7508791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADC","BK4231","BK4080","BK1161","02315"],"gpt_icon":0},{"id":"2569979769","title":"長城基金譚小兵：三重邏輯驅動創新藥 看好ADC等細分領域","url":"https://stock-news.laohu8.com/highlight/detail?id=2569979769","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569979769?lang=zh_tw&edition=fundamental","pubTime":"2025-09-23 13:37","pubTimestamp":1758605820,"startTime":"0","endTime":"0","summary":"今年以来，创新药板块表现亮眼，成为引领市场上行的主流板块之一。创新药板块哪些细分领域机会值得重点关注？围绕这些问题，长城基金权益投资部副总经理、基金经理谭小兵近日接受了媒体采访，我们一起来看她的解读。　　谭小兵：2025年以来，创新药板块的显著上涨是基本面突破、政策支持与估值修复三重因素共振的结果。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2025-09-23/doc-infrnekt7652526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK4231","159992","BK1161","BK4080","ADC","06978"],"gpt_icon":0},{"id":"2569059822","title":"百奧賽圖「雙業務線」持續放量：多項國際合作開啓新階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2569059822","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569059822?lang=zh_tw&edition=fundamental","pubTime":"2025-09-22 14:07","pubTimestamp":1758521220,"startTime":"0","endTime":"0","summary":"近期，百奥赛图在全球创新药产业链上的存在感愈发强烈。进入9月，公司接连发布三项合作消息，涵盖核酸药物递送、ADC研发与双抗ADC合作项目进展，充分展现了其“双业务线”战略的纵深布局与国际竞争力。　　该协议赋予默克独家选择权，一旦行权，百奥赛图将获得费用、里程碑付款以及销售分成。　　在创新药产业进入组合化、精准化的趋势下，百奥赛图通过“双业务线”逻辑已成功实现从传统CRO到创新型平台企业的跨越。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/enterprise/hk/2025-09-22/doc-infrizmi4651261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1699723380.USD","BK4007","LU1941712264.USD","MRK","SG9999015358.SGD","LU2023250504.SGD","SG9999002232.USD","LU0211331839.USD","LU1037948897.HKD","LU0320765646.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1037948541.HKD","LU1989771016.USD","ADC","LU0098860793.USD","LU1093756325.SGD","LU1116320901.HKD","LU0106261372.USD","LU1430594728.SGD","LU2361045086.USD","LU0208291251.USD","LU2361044949.HKD","IE00BLSP4452.SGD","BK4533","BK4559","LU1093756168.USD","LU2112291526.USD","IE00BLSP4239.USD","BK4080","LU1023059063.AUD","LU1571399168.USD","IE00B1BXHZ80.USD","LU0289739699.SGD","LU0985320562.USD","IE00BSNM7G36.USD","BK4588","SG9999014575.USD","IE00BFTCPJ56.SGD","LU0861579265.USD","LU1162221912.USD","LU1934455277.USD","SG9999002224.SGD","LU2468319806.SGD","IE0002141913.USD","BK4231","IE00BJJMRZ35.SGD","LU1069347547.HKD","LU1983299246.USD","LU2106854487.HKD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":182,"code":"91000000","status":"200"}]}}